Syros Pharmaceuticals Is A Biopharmaceutical Company Based In Cambridgemassachusettsfounded In 2011The Company Specializes In Developing Therapies For Cancer And Genetic Diseases By Targeting Gene Regulatory Circuitssyros Aims To Advance Disease Treatment Through Its Proprietary Platformwhich Identifies Key Regulatory Regions Of The Genome To Create Precision Medicines The Company S Pipeline Features Several Small Molecule Therapiesincluding Sy 2101An Oral Arsenic Trioxide For Acute Promyelocytic Leukemiasy 5609A Selective Cdk7 Inhibitor For Solid Tumors And Hematologic Malignanciesand Sy 5007A Ret Inhibitor For Thyroid And Non Small Cell Lung Cancerssyros Collaborates With Larger Pharmaceutical Firms To Enhance Its Drug Development Efforts And Focuses On Addressing Unmet Medical Needs In Oncology And Genetic Disorders
